Butros Fakhoury

6PUBLICATIONS
23CO-AUTHORS
Disease surveillanceMedical infection agents (incl. prions)Medical biochemistry - lipidsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 28, 2026
Post-Endoscopy Upper Gastrointestinal Cancer in a United States Multicenter Cohort: Site- and Risk-Stratified Trends and Survival.

|Aug 08, 2026
Liver donor macrosteatosis is associated with adverse long-term outcomes exclusively in metabolic dysfunction-associated steatotic liver disease recipients: a U.S. transplant registry analysis over the last decade.

|Jul 30, 2026
Prognostic significance of prior alcohol use disorder in patients with presumed metabolic dysfunction-associated steatotic liver disease: A large multi-center cohort study.

|Oct 21, 2025
The Cannabinoid System as a Potential Novel Target for Alcohol-Associated Liver Disease: A Propensity-Matched Cohort Study.

Butros Fakhoury, Vinay Jahagirdar, Kaanthi Rama

|Oct 07, 2025
Evolving trends and comparative outcomes of bridging transarterial locoregional therapy in liver transplant candidates with hepatocellular carcinoma.

Butros Fakhoury, Vinay Jahagirdar, Marwan Alsaqa

|Sep 02, 2025
Statin Therapy and Portal Pressure Reduction in Cirrhosis: A Systematic Review and Meta-Analysis.

Eyad Abdulrazzak, Butros Fakhoury, Ali Jaan

Pageof 1

Frequent Collaborators

3 joint publications

Leandro Sierra

3 joint publications

Vinay Jahagirdar

3 joint publications

Juan Pablo Arab

3 joint publications

Luis Antonio Díaz